Publication | Closed Access
Diallyl disulfide inhibits growth and metastatic potential of human triple‐negative breast cancer cells through inactivation of the β‐catenin signaling pathway
85
Citations
39
References
2015
Year
Our results show that the antitumor effect of DADS on TNBC cells is mediated by the β-catenin pathway, suggesting that DADS could be used as a potential therapeutic agent for treating or preventing breast cancer.
| Year | Citations | |
|---|---|---|
2011 | 55K | |
2008 | 2.9K | |
2007 | 858 | |
2005 | 273 | |
2011 | 268 | |
2001 | 258 | |
2011 | 210 | |
2013 | 120 | |
2008 | 119 | |
2012 | 114 |
Page 1
Page 1